161 related articles for article (PubMed ID: 4917326)
1. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
De Michelis S; Paparella P; Seu V
Clin Ter; 1969 Jul; 50(1):11-26. PubMed ID: 4917326
[No Abstract] [Full Text] [Related]
2. [Clinico-experimental studies of the influence of Atherolip on lipid and carbohydrate metabolism].
Hammerl H; Kränzl C; Pichler O; Studlar M
Med Welt; 1969 Aug; 31():1715-7. PubMed ID: 4895455
[No Abstract] [Full Text] [Related]
3. [Clinical-experimental studies on lipid metabolism using Regelan].
Hammerl H
Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
[No Abstract] [Full Text] [Related]
4. Clofibrate and androsterone effect on serum lipids.
Orgain ES; Bogdonoff MD; Cain C
Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
[No Abstract] [Full Text] [Related]
5. [Hypolipemic effect of an association of an extractive mucopolysaccharide and the ethyl ester of the p-chlorophenoxyisobutyric acid].
Coscelli C; Palmari V; Gnudi A
Farmaco Prat; 1968 Sep; 23(9):482-90. PubMed ID: 4238440
[No Abstract] [Full Text] [Related]
6. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
Schatz IJ
Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
[No Abstract] [Full Text] [Related]
7. [Action of ethyl chlorophenoxyisobutyrate on several types of hyperlipidemia].
Beaumont V; Swynghedauw B; Beaumont JL; Himbert J
Rev Atheroscler (Paris); 1966; 8(1):12-20. PubMed ID: 5961026
[No Abstract] [Full Text] [Related]
8. [Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].
Bertulla A; Bertamino V; Solari E
Ateneo Parmense 1; 1971; 42(2):103-14. PubMed ID: 5154400
[No Abstract] [Full Text] [Related]
9. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
[No Abstract] [Full Text] [Related]
10. [Influence of beta-benzabutyramide on the blood lipids and on the thrombodensitogram].
Ferri F; Regazzini A; Pedini G
G Gerontol; 1970 Mar; 18(3):203-18. PubMed ID: 5473222
[No Abstract] [Full Text] [Related]
11. [Importance of the clofibrat in the treatment of lipid metabolism disorders].
Laubinger G
Med Klin; 1968 Jan; 63(4):139-42. PubMed ID: 5670163
[No Abstract] [Full Text] [Related]
12. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
Warembourg H; Jaillard J
Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
[No Abstract] [Full Text] [Related]
13. [Hyperlipidemias: occurrence, significance, therapy].
Knüchel F
Med Welt; 1967 Aug; 32():1848-60. PubMed ID: 5589916
[No Abstract] [Full Text] [Related]
14. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
Braunsteiner H; Herbst M; Sandhofer F; Sailer S
Dtsch Med Wochenschr; 1967 Dec; 92(50):2302-8. PubMed ID: 6075896
[No Abstract] [Full Text] [Related]
15. [Atherosclerosis and Regelan].
Schwaar R
Praxis; 1966 Aug; 55(31):875-80. PubMed ID: 5953569
[No Abstract] [Full Text] [Related]
16. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
Rilliet B; Monnier J
Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485
[No Abstract] [Full Text] [Related]
17. The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate).
Oliver MF
Bull N Y Acad Med; 1968 Aug; 44(8):1021-7. PubMed ID: 4875747
[No Abstract] [Full Text] [Related]
18. [The effect of Atromid treatment of patients with essential hyperlipidemia and xanthomatosis].
Baranova LV
Ter Arkh; 1967 Jul; 39(7):61-3. PubMed ID: 5610932
[No Abstract] [Full Text] [Related]
19. [Effect of ethyl alpha-p-chlorophenoxyisobutyrate (Clofibrate) on lipids, cholesterol and uric acid in diabetes mellitus].
Orsetti A; Mirouze J
Therapie; 1966; 21(3):685-91. PubMed ID: 5942133
[No Abstract] [Full Text] [Related]
20. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
Vannas S; Esilä R; Tuovinen E
Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
[No Abstract] [Full Text] [Related]
[Next] [New Search]
